An improved version of the hairpin ribozyme functions as a ribonucleoprotein complex.
An improved version of the hairpin ribozyme functions as a ribonucleoprotein complex.
复制标题
发夹核酶的改进版本起到核糖核蛋白复合物的作用。
DOI:
10.1021/bi00023a021
复制
发表时间:
1995
期刊:
影响因子:
2.9
通讯作者:
Burke,JM
中科院分区:
文献类型:
--
作者:
Sargueil,B;Pecchia,DB;Burke,JM
Revised Manuscript Received March 31, 1995® abstract: Most RNA molecules that are endowed with catalytic activity function in the form of ribonucleoproteins within cells. These complexes are frequently large, poorly defined, and difficult to study. As a model system to study biological catalysis by ribonucleoproteins, we have modified the hairpin ribozyme by inserting an RNA structure that serves as a binding site for bacteriophage R17 coat protein in the form of an extension to ribozyme helix 4, which lies at the periphery of the catalytic domain. In the absence of protein, we find that incorporation of the protein-binding domain increases the catalytic efficiency of the hairpin ribozyme by 2-fold for the cleavage reaction and 16-fold for the ligation reaction. This increase in activity correlates with an increase in the proportion of molecules which fold into the active tertiary structure, as measured by a UV cross-linking assay. Mobility-shift and filter-binding assays of complex formation show that R17 coat protein bindsto the chimeric ribozyme with a dissociation constant essentially identical to that of the isolated protein-binding domain; no binding of the protein to the unmodified ribozyme could be detected. The kinetics of cleavage and ligation reactions are not altered by the presence of saturating concentrations of coat protein, and competition studies demonstrate that the protein remains boundto the ribozyme throughout the catalytic cycle. These studies establish that the hairpin ribozyme can be engineered to function efficiently in the form of a ribonucleoprotein in vitro and will serve as the basis for future experimentation to understand mechanisms of protein modulation of catalytic RNA activity, and to introduce other protein-binding domains, for example, HIV-1 rev-binding and tar elements, which may be useful for influencingsubcellular localization, regulating intracellular activity, or generating ribozymes that also function as “decoys” in antiviral applications.Ribozymes are RNA molecules that have been shown, through in vitro studies, to catalyze reactions in the absence of proteins. Although a number of different catalytic RNA motifs have been characterized, many biological reactions are known to be mediated not by RNA alone but by ribonucleoprotein (RNP) 1 complexes. RNP-mediated reac-tions lie at the heart of central cellular pathways, including nuclear pre-mRNA splicing catalyzed by the spliceosome, ribosomal protein synthesis, and protein translocation across membranes mediated by the signal recognition particle (SRP)(for review, see Wittop Koning and Schiimperli (1994)). Even in the case of RNA molecules that function without proteins in vitro, there is strong genetic and biochemical evidence that protein factors are essential for catalytic function in vivo. Two noteworthy examples are ribonuclease P, where a protein cofactor (C5 protein in Escherichia coli) is required in vivo but notat high ionic strength in vitro (Guerrier-Takada et al., 1988; Reich et al., 1988), and a